EUVIMEDEUVIMED entdecken
Crossref

Lacrimal gland enlargement in thyroid eye disease

Khizar Rana, Carmelo Caltabiano, Mark Beecher, Sandy Patel, James Slattery, Weng Onn Chan, Garry Davis, Dinesh Selva

International Ophthalmology · 2024

DOI: 10.1007/s10792-024-03352-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Ophthalmology, 2024. Verfasst von Khizar Rana und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology and Visual Sciences, University of Adelaide, North Terrace, SA, 5000, Australia. khizar.rana@adelaide.edu.au. Hauptthemen laut MEDLINE: Graves Ophthalmopathy, Magnetic Resonance Imaging, Lacrimal Apparatus. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: This study aimed to investigate lacrimal gland (LG) enlargement in thyroid eye disease (TED) patients on magnetic resonance imaging (MRI). METHODS: A retrospective review was conducted on TED patients who had undergone fat-suppressed contrast-enhanced T1-weighted MRI of the orbits. The lacrimal gland was segmented on OsiriX in consecutive axial and coronal slices to determine its volume. Enlargement was defined as a volume greater than 1100mm3, based on previous normative data. Asymmetric enlargement was defined if one side was enlarged but the contralateral side was not. Clinical data including presentation (active/inactive) and presence or absence of dysthyroid optic neuropathy was evaluated. RESULTS: The study population consisted of 88 orbits from forty-four patients with a mean age of 53 ± 15 years, with 29 (65%) being female. Twelve patients (27%) had LG enlargement, with eight (18%) having bilateral enlargement and four (9%) having asymmetric enlargement. There was no significant difference in age (p = 0.17) or sex (p = 0.44) between the LG enlarged and non-enlarged groups. There was also no significant difference in the clinical activity (p = 0.46) or prevalence of dysthyroid optic neuropathy (p = 0.63) between the LG enlarged orbits and non-LG enlarged orbits. CONCLUSION: Lacrimal gland enlargement may be observed in approximately thirty percent of TED patients, with asymmetric enlargement in approximately ten percent of cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graves OphthalmopathyMagnetic Resonance ImagingLacrimal ApparatusHumansFemaleMaleMiddle AgedRetrospective StudiesAdultAgedHypertrophy

Stichwörter der Autor:innen

GravesLacrimal glandMagnetic resonance imagingThyroid eye disease

Autor:innen und Institutionen

  • Department of Ophthalmology and Visual Sciences, University of Adelaide, North Terrace, SA, 5000, Australia. khizar.rana@adelaide.edu.au.
  • Department of Ophthalmology, Royal Adelaide Hospital, Port Road, Adelaide, SA, 5000, Australia. khizar.rana@adelaide.edu.au.
  • Department of Ophthalmology and Visual Sciences, University of Adelaide, North Terrace, SA, 5000, Australia.
  • Department of Ophthalmology, Royal Adelaide Hospital, Port Road, Adelaide, SA, 5000, Australia.
  • Department of Medical Imaging, Royal Adelaide Hospital, Port Road, Adelaide, SA, 5000, Australia.

Zitieren

APA

Rana, K., Caltabiano, C., Beecher, M., Patel, S., Slattery, J., Chan, W. O., Davis, G., & Selva, D. (2024). Lacrimal gland enlargement in thyroid eye disease. International Ophthalmology. https://doi.org/10.1007/s10792-024-03352-x

Vancouver

Rana K, Caltabiano C, Beecher M, Patel S, Slattery J, Chan WO, et al. Lacrimal gland enlargement in thyroid eye disease. International Ophthalmology. 2024. doi:10.1007/s10792-024-03352-x

BibTeX
@article{Rana2024,
  author = {Rana, Khizar and Caltabiano, Carmelo and Beecher, Mark and Patel, Sandy and Slattery, James and Chan, Weng Onn and Davis, Garry and Selva, Dinesh},
  title = {Lacrimal gland enlargement in thyroid eye disease},
  journal = {International Ophthalmology},
  year = {2024},
  doi = {10.1007/s10792-024-03352-x}
}
Kostenlos starten →